Gore aneurysm treatment gets US FDA panel backing
This article was originally published in Clinica
A thoracic aneurysm stent graft has won the backing of an FDA advisory, giving rise to the prospect that thoracic surgeons will be able to opt to avoid potentially risky open surgical repair of deadly aneurysms.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.